Jiangsu Hengrui Medicine repurchases shares for employee stock plan

Jiangsu Hengrui Medicine Co., Ltd. disclosed a significant change in its issued share capital following a share repurchase conducted on September 11, 2025. The company bought back 235,000 A-shares, which are to be held as treasury stock for an employee stock ownership plan. This buyback reduced the number of issued shares (excluding treasury shares) from 6,370,380,964 to 6,370,145,964, representing 0.004% of the existing issued shares before the event.

The repurchase was executed on another securities exchange at prices ranging from RMB 67.2 to RMB 68.41 per share, with a total cost of RMB 15,926,550. Following this transaction, the total number of treasury shares increased from 8,621,310 to 8,856,310, while the overall total issued shares remained unchanged at 6,379,002,274. The company confirmed that the share repurchase activity on the other securities exchange was conducted in accordance with the applicable rules of that exchange.